EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial

Yunyi Han, Fang Jin, Jimmy Lee, Wenpeng Hou, Xue Yang, Yiming Zhang, Yueying Zhang, Xuefeng Lu, Zhimin Wang, Qijing Bo, Zhengyi Yang, Fuchun Zhou und 2 weitere

Brain Stimulation · 2025

DOI: 10.1016/j.brs.2025.03.014 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Brain Stimulation, 2025. Verfasst von Yunyi Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing An…. Hauptthemen laut MEDLINE: Schizophrenia, Transcranial Magnetic Stimulation, Ventral Tegmental Area, Dorsolateral Prefrontal Cortex. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Capital Medical University, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The efficacy of non-invasive brain stimulation in ameliorating schizophrenia's negative symptoms remains to be validated. The mesocortical pathway, mostly comprising the ventral tegmental area (VTA) and prefrontal cortex, is the core neural circuit underlying negative symptoms. This study aimed to assess the clinical and biological effects of accelerated intermittent theta burst stimulation (iTBS) targeted to the dorsolateral prefrontal cortex (dlPFC), guided by personalised dlPFC-VTA functional connectivity (FC). METHODS: Eighty schizophrenia patients with predominant negative symptoms received 40 sessions of either active (n = 40) or sham (n = 40) accelerated iTBS (1800 pulses) in two weeks, targeting the region of the left dlPFC most functionally correlated with the VTA. Clinical and cognitive follow-ups occurred at week 4, 8, and 12. The primary outcome was the alteration in PANSS negative symptom (PANSS-NS) scores at week 4, while secondary outcomes included additional clinical, cognitive assessments and neuroimaging alterations. RESULTS: At week 4, the active group showed a significant reduction in PANSS-NS compared to the sham group, with a significant group × time interaction effect (P < 0.001, mean difference = 4.10, Cohen's d = 0.83). At week 2, compared to the sham group, the active group exhibited reduced left temporal middle gyrus (TMG) (r = -0.29, p = 0.01) activation and FC between the VTA and left TMG (r = -0.34, p = 0.003), and both were negatively correlated with PANSS-NS changes in both groups. CONCLUSION: Accelerated iTBS targeting the personalised region determined by dlPFC-VTA FC is an effective intervention to alleviate negative symptoms of schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaTranscranial Magnetic StimulationVentral Tegmental AreaDorsolateral Prefrontal CortexHumansMaleFemaleAdultMiddle AgedTreatment OutcomeYoung AdultPrecision Medicine

Stichwörter der Autor:innen

Functional connectivityIntermittent theta burst stimulationNegative symptomsSchizophreniaVentral tegmental area

Autor:innen und Institutionen

  • Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 10088, China; Adva…
  • Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
  • Institute of Mental Health, Singapore, 636921, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 636921, Singapore.
  • The First Psychiatric Hospital of Harbin, Harbin, Heilongjiang, 150026, China.
  • School of Basic Medical Sciences, Capital Medical University, Beijing , 100069, China.
  • Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. Electronic address: zhengyi.yang@nlpr.ia.ac.cn.

Förderung

  • National Natural Science Foundation of China
  • Capital Medical University
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Han, Y., Jin, F., Lee, J., Hou, W., Yang, X., Zhang, Y., Zhang, Y., Lu, X., Wang, Z., Bo, Q., Yang, Z., Zhou, F., Jiang, T., & Wang, C. (2025). Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial. Brain Stimulation. https://doi.org/10.1016/j.brs.2025.03.014

Vancouver

Han Y, Jin F, Lee J, Hou W, Yang X, Zhang Y, et al. Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial. Brain Stimulation. 2025. doi:10.1016/j.brs.2025.03.014

BibTeX
@article{Han2025,
  author = {Han, Yunyi and Jin, Fang and Lee, Jimmy and Hou, Wenpeng and Yang, Xue and Zhang, Yiming and Zhang, Yueying and Lu, Xuefeng and Wang, Zhimin and Bo, Qijing and Yang, Zhengyi and Zhou, Fuchun and Jiang, Tianzi and Wang, Chuanyue},
  title = {Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial},
  journal = {Brain Stimulation},
  year = {2025},
  doi = {10.1016/j.brs.2025.03.014}
}
Kostenlos starten →